Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuro-Oncology Associates is a specialized medical practice and clinical research entity focused on the diagnosis and treatment of primary and metastatic brain and spinal cord tumors. Led by prominent neuro-oncologists, the group provides comprehensive care including chemotherapy, targeted biological therapies, and innovative treatments like Tumor Treating Fields (Optune). In addition to clinical practice, the organization frequently participates in multi-center clinical trials, evaluating new therapeutic agents and protocols for aggressive malignancies such as glioblastoma. They serve as a key regional provider for neuro-oncological expertise, bridging the gap between standard oncological care and advanced neurological research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuro-Oncology Associates.